학술논문
Goserelin, as an ovarian protector during (neo)adjuvant breast cancer chemotherapy, prevents long term altered bone turnover
Document Type
Article
Author
Source
In Journal of Bone Oncology March 2016 5(1):43-49
Subject
Language
ISSN
2212-1374